CD86 and melanoma: Nevertheless, future studies would benefit from the application of more advanced histological and imaging techniques, such as fluorescent or multiplex immunohistochemistry, with additional markers including pSTAT1, INOS, CD80, and CD86, in order to obtain a more detailed characterization of macrophage subpopulations in melanoma.